Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 912,700 | 869,600 | 831,100 | 799,000 | 753,000 |
| Cost of Goods | 83,600 | 69,000 | 68,300 | 71,000 | 60,000 |
| Gross Profit | 829,100 | 800,600 | 762,800 | 728,000 | 693,000 |
| Operating Expenses | 603,000 | 588,600 | 635,700 | 549,000 | 498,000 |
| Operating Income | 226,700 | 212,000 | 127,400 | 179,000 | 195,000 |
| Interest Expense | 24,800 | 23,500 | 24,900 | 24,000 | 24,000 |
| Other Income | 4,400 | 5,500 | 1,700 | 4,000 | -1,000 |
| Pre-tax Income | 206,300 | 194,000 | 104,200 | 159,000 | 170,000 |
| Income Tax | 41,100 | 23,900 | 10,800 | 65,000 | 50,000 |
| Net Income Continuous | 165,200 | 170,100 | 93,400 | 94,000 | 120,000 |
| Net Income | $165,200 | $170,100 | $93,400 | $94,000 | $120,000 |
| EPS Basic Total Ops | 0.74 | 0.76 | 0.41 | 0.42 | 0.54 |
| EPS Basic Continuous Ops | 0.74 | 0.76 | 0.42 | 0.42 | 0.54 |
| EPS Diluted Total Ops | 0.73 | 0.75 | 0.40 | 0.42 | 0.53 |
| EPS Diluted Continuous Ops | 0.73 | 0.75 | 0.41 | 0.42 | 0.53 |
| EBITDA(a) | $359,300 | $311,600 | $228,800 | $279,000 | $293,000 |